Skip to Main Content

In an unusual move, a private equity firm is soliciting investors to help create a chain of cancer centers that would focus on providing experimental medicines that are available under the controversial Right to Try law that went into effect two years ago.

Earlier this month, Vivaris Capital began touting United Cancer Centers, which is described as the “first institutional health care system” in the U.S. to offer “integrative cancer care.” A big selling point for patients will be helping them obtain medicines under the Right to Try law, which largely cuts the Food and Drug Administration out of the process for determining when dying patients can access experimental drugs being studied in clinical trials.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Comments are closed.